Lactate dehydrogenase-to-albumin ratio: A superior inflammatory marker for predicting contrast-associated acute kidney injury after percutaneous coronary intervention,Clinical Cardiology

当前位置： X-MOL 学术 › Clin. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Lactate dehydrogenase-to-albumin ratio: A superior inflammatory marker for predicting contrast-associated acute kidney injury after percutaneous coronary intervention
Clinical Cardiology ( IF 2.7 ) Pub Date : 2024-01-29 , DOI: 10.1002/clc.24219
Ji‐Lang Zeng _{1,

2,

3} , Jun‐Han Chen _{1,

2,

3} , Li‐Wei Zhang _{1,

2,

3} , Li‐Chuan Chen _{1,

2,

3} , Wen‐Jia Liang _{1,

2,

3} , Zhebin You _{2,

3,

4} , Kai‐Yang Lin _{1,

2,

3} , Yansong Guo _{1,

2,

3}

Affiliation

Inflammation is commonly considered a mechanism underlying contrast-associated acute kidney injury (CA-AKI). This study aimed to explore the predictive capability of the novel inflammatory marker lactate dehydrogenase-to-albumin ratio (LAR) for CA-AKI following percutaneous coronary intervention (PCI), and further compare it with other common inflammatory biomarkers.

中文翻译：

乳酸脱氢酶与白蛋白的比率：预测经皮冠状动脉介入治疗后造影剂相关急性肾损伤的优质炎症标志物

炎症通常被认为是造影剂相关急性肾损伤（CA-AKI）的潜在机制。本研究旨在探讨新型炎症标志物乳酸脱氢酶与白蛋白比值（LAR）对经皮冠状动脉介入治疗（PCI）后CA-AKI的预测能力，并进一步将其与其他常见炎症生物标志物进行比较。

更新日期：2024-01-30

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>